New Animal Drugs for Minor Use and Minor Species
---
identifier: "/us/fr/2012-7532"
source: "fr"
legal_status: "authoritative_unofficial"
title: "New Animal Drugs for Minor Use and Minor Species"
title_number: 0
title_name: "Federal Register"
section_number: "2012-7532"
section_name: "New Animal Drugs for Minor Use and Minor Species"
positive_law: false
currency: "2012-03-28"
last_updated: "2012-03-28"
format_version: "1.1.0"
generator: "[email protected]"
agency: "Health and Human Services Department"
document_number: "2012-7532"
document_type: "rule"
publication_date: "2012-03-28"
agencies:
- "Health and Human Services Department"
- "Food and Drug Administration"
cfr_references:
- "21 CFR Part 516"
fr_citation: "77 FR 18685"
fr_volume: 77
---
# Content and format of a request for MUMS-drug designation.
**CFR Correction**
**21 CFR Part 516**
In Title 21 of the Code of Federal Regulations, Parts 500 to 599, revised as of April 1, 2011, on page 96, in § 516.20, (b)(2) is revised to read as follows:
§ 516.20
(b) * * *
(2) The name and address of the sponsor; the name of the sponsor's primary contact person and/or permanent-resident U.S. agent including title, address, and telephone number; the established name (and proprietary name, if any) of the active pharmaceutical ingredient of the drug; and the name and address of the source of the active pharmaceutical ingredient of the drug.